J. McCarty

发表

Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis.

M. Ferguson, A. Chait, C. Benjamin, 1993, The Journal of clinical investigation.

Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.

A. Nademanee, J. Dipersio, G. Bridger, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Peripheral-blood stem cells versus bone marrow from unrelated donors.

P. Westervelt, S. Mineishi, D. Porter, 2012, The New England journal of medicine.

Improving stem cell mobilization strategies: future directions

J. Dipersio, J. McCarty, W. Bensinger, 2009, Bone Marrow Transplantation.

Stem Cell Transplantation as a Dynamical System: Are Clinical Outcomes Deterministic?

M. Neale, G. Buck, N. Sheth, 2014, Front. Immunol..

Treatment of acute fibrinous organizing pneumonia following hematopoietic cell transplantation with etanercept

H. Chung, J. McCarty, Harold M. Chung, 2016, Bone Marrow Transplantation.

Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report.

A. Nademanee, J. Dipersio, J. Kaufman, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotype.

Zhuyin Li, S. Mukherjee, G. Jarai, 2019, American journal of translational research.

Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice.

J. Whitsett, T. Korfhagen, J. McCarty, 1994, The Journal of clinical investigation.

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.

J. Dipersio, R. Soiffer, R. Negrin, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allograft Rejection

G. Daughters, C. Alpers, C. Benjamin, 2005 .

Transplantation Using Bone Marrow from a (very) HLA Mismatched Unrelated Donor in the Setting of Post-Transplant Cyclophosphamide Is Feasible and Expands Access to Underserved Minorities

M. Norkin, M. Perales, M. Horowitz, 2020 .

Transplant strategies for myelodysplastic syndrome.

J. McCarty, 2004, Best practice & research. Clinical haematology.

Larger Numbers of Donor Naïve CD8+ T-Cells and Plasmacytoid Dendritic Cell Precursors In Allogeneic BM Grafts From Unrelated Donors Are Associated with Improved Survival: Results From BMT CTN 0201

Cathy Gurgol, S. Mineishi, D. Porter, 2011 .

The Influence of Lymphoid Reconstitution Kinetics on Clinical Outcomes in Allogeneic Stem Cell Transplantation

R. Sabo, J. McCarty, Harold M. Chung, 2016, bioRxiv.

PEPCK mRNA localization in proximal tubule and gene regulation during metabolic acidosis.

A. Moorman, W. Lamers, A. Schoolwerth, 2002, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Transplant strategies for idiopathic myelofibrosis.

J. McCarty, 2004, Seminars in hematology.

Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901.

K. Owzar, P. Westervelt, S. Farag, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data

G. Tricot, G. Bridger, K. Badel, 2008, Bone Marrow Transplantation.

Massive Mobilization of AML Cells into Circulation by Disruption of Leukemia/Stroma Cell Interactions Using CXCR4 Antagonist AMD3100: First Evidence in Patients and Potential for Abolishing Bone Marrow Microenvironment-Mediated Resistance.

E. Estey, M. Konopleva, M. Andreeff, 2006 .

Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocol.

J. Dipersio, G. Bridger, G. Calandra, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Experience with Plerixafor in Poor Mobilizers

J. McCarty, C. Roberts, 2012 .

Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen‐specific cellular immunity

R. Sabo, M. Manjili, J. McCarty, 2012, British journal of haematology.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

P. Hari, J. Varni, W. Tse, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dynamical System Modeling Of Immune Reconstitution Following Allogeneic Stem Cell Transplantation Identifies Patients At Risk For Adverse Outcomes

M. Neale, R. Sabo, M. Manjili, 2014, 1412.4416.

Pyridoxine as therapy in theophylline-induced seizures.

M. Weir, J. McCarty, P. Kelly, 1995, Veterinary and human toxicology.

Distinct Oligoclonal T Cells Are Associated With Graft Versus Host Disease After Stem-Cell Transplantation

R. Sabo, M. Manjili, J. McCarty, 2012, Transplantation.

Favorable outcomes in patients with high donor-derived T cell count after in vivo T cell-depleted reduced-intensity allogeneic stem cell transplantation.

M. Neale, R. Sabo, M. Manjili, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mycotic osteomyelitis due to Scedosporium Apiospermum: MR imaging-pathologic correlation

J. McCarty, T. Knight, S. Kaushik, 2003, Skeletal Radiology.

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

J. Dipersio, J. Liesveld, S. Devine, 2005, Blood.

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

R. Advani, J. Briones, G. Salles, 2019, The Lancet.

The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.

W. Wood, P. Chiusolo, R. Storb, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice

S. Steinberg, S. Mitchell, M. Datiles, 2015, Haematologica.

M. McNeil, J. McCarty, C. R. LeProwse, 1989, Journal of clinical microbiology.

Granulomatous myositis: a manifestation of chronic graft-versus-host disease

C. Wise, J. McCarty, S. Kaushik, 2002, Skeletal Radiology.

Palifermin for oral mucositis after intensive therapy for hematologic cancers

T. Shea, D. Weisdorf, B. Blazar, 2017 .

A preliminary investigation into the action of anagrelide: thrombopoietin-c-Mpl receptor interactions.

G. Warshamana-Greene, P. Melone, J. McCarty, 2006, Experimental hematology.

Hematologic aspects of myeloablative therapy and bone marrow transplantation

R. Riley, J. Ben-Ezra, J. McCarty, 2005, Journal of clinical laboratory analysis.

Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients

R. Sabo, M. Manjili, H. Chung, 2012, Bone Marrow Transplantation.

Interleukin‐4 induces endothelial vascular cell adhesion molecule‐1 (VCAM‐1) by an NF‐κb‐independent mechanism

K. Kaushansky, J. Harlan, J. McCarty, 1995, FEBS letters.

Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)

C. Bloomfield, R. Larson, W. Stock, 2014, Haematologica.

Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.

E. Leifer, H. Deeg, J. Tolar, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplant cyclophosphamide: follow-up from a National Marrow Donor Program-sponsored prospective clinical trial.

M. Norkin, M. Perales, J. Pidala, 2022, Transplantation and cellular therapy.

National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide

M. Norkin, M. Perales, M. Horowitz, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis BMT CTN 1101Open for Accrual June 2012Open for Accrual June 2012.

B. Logan, J. Magenau, C. Cutler, 2022, Transplantation and cellular therapy.

Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.

E. Leifer, H. Deeg, M. Horowitz, 2015, The Lancet. Haematology.

Pharmacoeconomics of hematopoietic stem cell mobilization: an overview of current evidence and gaps in the literature.

Pieter J. Helmons, N. Chao, J. McCarty, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.

S. Mineishi, D. Porter, T. Spitzer, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cell Mobilization is Superior to G-CSF Alone The Use of AMD3100 Plus G-CSF for Autologous Hematopoietic Progenitor

J. Dipersio, J. Liesveld, S. Devine, 2013 .

P. Hari, W. Tse, M. Horowitz, 2018, Haematologica.

Are We Overlooking the Use of Oral Ribavirin for Respiratory Syncytial Virus Infection Following Hematopoietic Stem Cell Transplantation?

J. McCarty, Harold M. Chung, F. Silveira, 2019, Current Treatment Options in Infectious Diseases.

Managing post allograft relapse of myeloid neoplasms: azacitidine and donor lymphocyte infusions as salvage therapy

J. McCarty, Harold M. Chung, M. Aziz, 2019, Leukemia & lymphoma.

Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin’s lymphoma and multiple myeloma: results from the expanded access program

P. Mcsweeney, S. Devine, D. Johns, 2013, Bone Marrow Transplantation.

Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.

Jeremy Meier, Shiyu Song, Kristin Miller, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Killer Immunoglobulin-like Receptor-Ligand Interactions Predict Clinical Outcomes Following Unrelated Donor Transplants

R. Sabo, A. Keating, P. Kimball, 2019, bioRxiv.

Neuronal nitric oxide synthase: expression in rat parietal cells.

M. Zaki, R. Johns, P. Melone, 2001, American journal of physiology. Gastrointestinal and liver physiology.

Bridging the Gap in Access to Transplant for Underserved Minority Patients Using Mismatched Unrelated Donors and Post-Transplant Cyclophosphamide: A National Marrow Donor Program/be the Match (NMDP/BTM) Initiative

M. Norkin, M. Perales, M. Horowitz, 2020 .

Autologous Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Achieves Outcomes Similar to Allogeneic Transplantation - Results of CALGB 10001 (Alliance)

C. Bloomfield, K. Owzar, R. Larson, 2012 .

Low-dose splenic irradiation prior to hematopoietic cell transplantation in hypersplenic patients with myelofibrosis

N. Mukhopadhyay, J. McCarty, Harold M. Chung, 2017, Leukemia & lymphoma.

Exchange Activity in Taste Receptor Cells + -H + Na

Paul V. Watkins, J. Voipio, K. Kaila, 2015 .

Na+-H+ exchange activity in taste receptor cells.

M. Knepper, J. Desimone, V. Lyall, 2004, Journal of neurophysiology.

Maintenance azacitidine after myeloablative allogeneic hematopoietic cell transplantation for myeloid malignancies

R. Sabo, J. McCarty, A. Toor, 2018, Leukemia & lymphoma.

Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation

J. Vose, P. Riedell, Sonali M. Smith, 2021, British journal of haematology.

Successful Stem Cell Mobilization Rescue by AMD3100 (Plerixafor)+G-CSF for Patients Who Failed Primary Mobilization: Results from the Phase III (3101-NHL) Study.

J. Dipersio, G. Bridger, G. Calandra, 2007 .

Immune Reconstitution In Anti-Thymocyte Globulin Conditioned Unrelated Donor Stem Cell Transplantation

R. Sabo, J. McCarty, Harold M. Chung, 2013 .

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

M. Dhodapkar, P. Westervelt, M. Perales, 2023, eClinicalMedicine.

Bronchoalveolar lavage to evaluate new pulmonary infiltrates in allogeneic hematopoietic stem cell transplant recipients: impact on antimicrobial optimization

J. McCarty, M. Stevens, C. Roberts, 2019, Infection Prevention in Practice.

Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.

V. Broudy, N. Fox, K. Kaushansky, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Murine thrombopoietin mRNA levels are modulated by platelet count.

N. Fox, K. Kaushansky, J. McCarty, 1995, Blood.

Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single dose velafermin (CG53135-05) for the prevention of oral mucositis.

E. Anaissie, Y. Halvorsen, R. Maziarz, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.

M. Neale, R. Sabo, M. Manjili, 2015, Biology of Blood and Marrow Transplantation.

Peripheral-blood stem cells versus bone marrow from unrelated donors.

P. Westervelt, S. Mineishi, D. Porter, 2012, The New England journal of medicine.

The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.

W. Wood, P. Chiusolo, R. Storb, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effectiveness and toxicity of high-dose cyclophosphamide in obese versus non-obese patients receiving allogeneic hematopoietic stem cell transplant*

R. Sabo, J. McCarty, A. Newland, 2016, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Expression of vascular cell adhesion molecule-1 in kidney allograft rejection.

C. Alpers, C. Benjamin, K. Hudkins, 1993, Kidney international.

Expression of vascular cell adhesion molecule-i in kidney allograft rejection

C. Alpers, C. Benjamin, C. Marsh, 1993 .

Low Plasma Vitamin C Levels in Patients Undergoing Stem Cell Transplantation

A. Fowler, B. Fisher, K. Leslie, 2017 .